Vaccination and Platelet Biology: Unraveling the Immuno-Hemostatic Interplay

Platelets, which have been traditionally associated with hemostasis and thrombosis functions, now receive attention for their role in immune responses that may affect vaccine development and effectiveness. Through their interactions with immune cells and modulation of inflammation alongside their role in antigen presentation, platelets become integral components of both innate and adaptive immune systems. New research shows platelets can improve vaccine effectiveness while reducing adverse side effects. During vaccine administration, platelets release cytokines and chemokines, which attract and stimulate immune cells to the injection site. Platelets work together with dendritic cells and T cells to support antigen processing and presentation, which leads to strong immune activation. Platelets' pro-inflammatory mediators strengthen local immune responses to boost protective immunity generation. Significant attention has been given to platelet involvement in vaccine-related thrombotic events, including vaccine-induced immune thrombotic thrombocytopenia (VITT). The rarity and severity of these events demonstrate the need to investigate the complex interplay between vaccine mechanisms and platelet activation. Exploration of the platelet-immune axis can lead to new methods for improving both the effectiveness and safety of vaccines. Researchers are working on creating innovative approaches for treatments that target platelet receptors and thrombosis pathways without interfering with the regular hemostatic functions of platelets. New vaccine development methods and personalized immunization strategies can emerge from targeting platelets with adjuvants and immune modulators.